Company Monitoring Page for JNJ

latest headlines for company on cafepharma

FDA Is Restricting This Johnson & Johnson Drug
Wall St. Cheat Sheet
Mon, 07/29/13 - 10:36 am
Tags:
antifungals, FDA, JNJ, Nizoral
FDA limits use of J&J's Nizoral antifungal drug on safety concerns
Reuters
Fri, 07/26/13 - 11:25 am
Tags:
FDA, JNJ, Nizoral, antifungals
Breakthrough Status May Spur J&J Drug to Market Early
Bloomberg
Thu, 07/25/13 - 10:42 am
Tags:
JNJ, breakthrough therapies, ibrutinib, Pharmacyclics, chronic lymphocytic leukemia, mantle cell lymphoma
Why Johnson & Johnson's Long-Term Tailwinds Remain Intact
Seeking Alpha
Wed, 07/24/13 - 10:18 am
Tags:
JNJ
The Diabetes Pipeline With a Clog
Motley Fool
Mon, 07/22/13 - 06:02 pm
Tags:
diabetes, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, JNJ, SGLT2 inhibitor, Forxiga, Invokana, empagliflozin
Innovations In HIV: Johnson & Johnson, Glaxo Vs. Gilead
Seeking Alpha
Mon, 07/22/13 - 10:26 am
Tags:
HIV, Atripla, JNJ, Pfizer, GSK, Gilead, Dolutegravir, Edurant, China, TMC310911
Can This Pharmaceutical Power Stay Healthy?
Daily Finance
Sat, 07/20/13 - 11:51 am
Tags:
JNJ
J&J Agrees to Pay $22.9 Million to Settle on Drug Recalls
Bloomberg
Thu, 07/18/13 - 09:09 am
Tags:
JNJ, recalls
J&J Pays $23M To Settle Class Action Suit Over OTC Troubles
Pharmalot
Wed, 07/17/13 - 11:10 am
Tags:
OTC, JNJ
J&J results beat expectations, as drugs, devices deliver
Reuters
Tue, 07/16/13 - 09:22 am
Tags:
earnings, JNJ
Johnson & Johnson (JNJ) Earnings Projected to Increase
Forbes
Mon, 07/15/13 - 10:25 am
Tags:
JNJ, earnings
This Week in Biotech
Motley Fool
Sun, 07/14/13 - 11:19 am
Tags:
Pharmacyclics, JNJ, Alnylam, Inovio, Alexion, Roche
A Developing "Breakthrough" In Biotechnology that You Should Monitor
Motley Fool
Sat, 07/13/13 - 12:31 pm
Tags:
Pharmacyclics, ibrutinib, blood cancer, JNJ, AbbVie
Broker Darlings of the Dow: Johnson & Johnson Ranks As a Top 15 Analyst Pick
Forbes
Sat, 07/13/13 - 12:04 pm
Tags:
JNJ
Johnson & Johnson Earnings Are on Deck
Motley Fool
Fri, 07/12/13 - 07:33 am
Tags:
earnings, JNJ
Laywer Spars With FDA Over J&J Risperdal Court Documents
Pharmalot
Thu, 07/11/13 - 12:10 pm
Tags:
FDA, JNJ, Risperdal
Astex Pharmaceuticals In Focus With Catalyst In The Near Term
Seeking Alpha
Thu, 07/11/13 - 11:15 am
Tags:
Astex, AstraZeneca, Celgene, GSK, JNJ, Novartis, SGI-110, Dacogen
Will This Be the Breakthrough of All Breakthrough Therapy Drugs?
Motley Fool
Thu, 07/11/13 - 11:09 am
Tags:
breakthrough therapies, ibrutinib, Pharmacyclics, JNJ, chronic lymphocytic leukemia
How Johnson & Johnson Revamped its Executive Pay Practices
Forbes
Wed, 07/10/13 - 01:31 pm
Tags:
JNJ, executive pay
Pharmacyclics and Johnson & Johnson submit blood cancer drug ibrutinib to FDA for approval
Yahoo/AP
Wed, 07/10/13 - 11:05 am
Tags:
JNJ, Pharmacyclics, ibrutinib, chronic lymphocytic leukemia

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.